Date published: 2025-10-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

KIAA1913 Activators

KIAA1913 Activators represent a collection of chemical entities that, through various signaling mechanisms, may amplify the functional activity of KIAA1913. Compounds like Forskolin and IBMX, known to enhance intracellular cAMP levels, could potentially enhance KIAA1913's activity by increasing protein kinase A (PKA) activity, which in turn could phosphorylate substrates that modulate KIAA1913's function. Similarly, PMA, as an activator of protein kinase C (PKC), could indirectly activate KIAA1913 through PKC-regulated pathways. Ionomycin and A23187, both calcium ionophores, raise intracellular calcium, which could activate calcium-dependent kinases or signaling molecules that intersect with KIAA1913's activity. Moreover, inhibitors like U0126 and PD98059 target the MEK component of the MAPK/ERK pathway, potentially altering KIAA1913 activity if KIAA1913 is implicated in this signaling cascade.

Rapamycin, by inhibiting mTOR signaling, could also indirectly modulate KIAA1913's function, assuming KIAA1913 operates downstream of mTOR. Staurosporine's broad-spectrum inhibition of protein kinases might lead to de-repression ofKIAA1913 Activators encompass a spectrum of chemical compounds that are theorized to indirectly enhance the activity of KIAA1913 through modulation of various signaling pathways. Forskolin, acting through adenylyl cyclase activation, leads to increased intracellular cAMP levels, potentially activating protein kinase A (PKA), which could lead to phosphorylation events that alter KIAA1913 activity. Similarly, IBMX, by inhibiting phosphodiesterases, raises cAMP levels, possibly leading to enhanced KIAA1913 activity through PKA-mediated phosphorylation. Phorbol 12-myristate 13-acetate (PMA), a known activator of protein kinase C (PKC), might influence KIAA1913 activity by affecting PKC-regulated pathways. Additionally, increases in intracellular calcium levels, achieved through ionophores like Ionomycin and A23187, may initiate calcium-dependent signaling cascades that could intersect with and activate KIAA1913.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Forskolin activates adenylyl cyclase, increasing intracellular cAMP levels. Elevated cAMP may activate PKA, which can phosphorylate various substrates potentially altering KIAA1913 activity through downstream signaling events.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$159.00
$315.00
$598.00
34
(1)

IBMX is a non-selective inhibitor of phosphodiesterases, leading to increased cAMP levels which could enhance PKA activity. This could indirectly activate KIAA1913 by modulating the protein's phosphorylation state if PKA substrates interact with KIAA1913.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

PMA (phorbol 12-myristate 13-acetate) activates protein kinase C (PKC), potentially influencing signaling cascades that affect KIAA1913 function, assuming KIAA1913 is downstream of PKC-regulated pathways.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$76.00
$265.00
80
(4)

Ionomycin is a calcium ionophore that increases intracellular calcium levels, potentially affecting calcium-dependent signaling pathways that KIAA1913 may be part of.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$54.00
$128.00
$199.00
$311.00
23
(1)

A23187 is another calcium ionophore, which by raising intracellular calcium levels could indirectly activate calcium/calmodulin-dependent protein kinases and possibly KIAA1913 if calcium signaling affects its activity.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

U0126 is a MEK inhibitor that may indirectly influence KIAA1913 activity by altering the MAPK/ERK signaling pathway, assuming KIAA1913 is involved in this pathway.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 is a PI3K inhibitor that might indirectly affect KIAA1913 activity by altering AKT signaling, which could intersect with KIAA1913's functional pathway.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD98059 is another MEK inhibitor that can alter MAPK/ERK signaling. This could influence KIAA1913 if there is a connection between ERK signaling and KIAA1913 activity.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin inhibits mTOR, which may affect KIAA1913 activity indirectly if KIAA1913 is part of signaling pathways downstream of mTOR.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

Staurosporine is a broad-spectrum protein kinase inhibitor that could potentially activate KIAA1913 by inhibiting kinases that normally maintain KIAA1913 in an inactive state.